Clinical trials

  • GIREDESTRANT for Estrogen receptor-positive, HER2-negative advanced breast cancer
  • PEMBROLIZUMAB for Advanced-stage classical Hodgkin lymphoma | Classical Hodgkin lymphoma
  • olpasiran for Atherosclerotic cardiovascular disease | Elevated lipoprotein(a)
  • CLOSTRIDIA, CLUSTER XIVA, STRAIN RELATIVE CLOSTRIDIUM_Q SYMBIOSUM, LIVE; CLOSTRIDIA, CLUSTER XIVA, STRAIN RELATIVE ENTEROCLOSTER BOLTEAE, LIVE; CLOSTRIDIA, CLUSTER XIVA, STRAIN RELATIVE SELLIMONAS INTESTINALIS, LIVE; CLOSTRIDIA, CLUSTER IV, STRAIN RELATIVE FLAVONIFRACTOR PLAUTII, LIVE; CLOSTRIDIA, CLUSTER XIVA, STRAIN RELATIVE BLAUTIA SP001304935, LIVE; BACILLI, CLUSTER XVII, STRAIN RELATIVE CLOSTRIDIUM_AQ INNOCUUM, LIVE; CLOSTRIDIA, CLUSTER XIVA, STRAIN RELATIVE DOREA_A LONGICATENA, LIVE; CLOSTRIDIA, CLUSTER IV, STRAIN RELATIVE ANAEROTRUNCUS COLIHOMINIS, LIVE for Clostridioides difficile infection
  • MODAFINIL for Multiple sclerosis | Relapsing-remitting multiple sclerosis | Clinically isolated syndrome
  • BIMEKIZUMAB for Palmoplantar pustulosis
  • AXATILIMAB for Idiopathic pulmonary fibrosis
  • NEMTABRUTINIB for Mantle cell lymphoma | Chronic lymphocytic leukemia | Follicular lymphoma | Richter's syndrome
  • GADOBUTROL for Idiopathic normal pressure hydrocephalus (INPH) | Cerebrospinal fluid circulation disorder
  • Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene for Frontotemporal dementia (FTD) with progranulin (GRN) mutations|Frontotemporal dementia
  • TRETINOIN for Oropharyngeal squamous cell carcinoma|Laryngeal squamous cell carcinoma|Hypopharyngeal squamous cell carcinoma
  • INSULIN ICODEC for Type 2 diabetes